Table 2.

Propofol usage, time parameters, and incidence of adverse events

Variable	Control group	Lidocaine group	OR	P value (95% CI)
Propofol induction dose, mg	63.2 ± 10.1	57.4 ± 11.6		0.112(−13.05, 1.42)
Propofol maintenance dose, mg	136.2 ± 49.6	71.2 ± 26.7		<0.001(−90.78, −39.22)
Total propofol dose, mg	199.4 ± 57.6	128.6 ± 30.4		<0.001(−100.60, −41.02)
Operation time, min	25.9 ± 7.0	24.0 ± 5.8		0.357(−6.03, 2.23)
Awakening time, min	11.2 ± 2.4	4.8 ± 1.4		<0.001(−7.67, −5.13)
Recovery time, min	13.7 ± 2.7	7.8 ± 2.1		<0.001(−7.45, −4.35)
Involuntary movement n (%)	8 (40)	2 (10)	0.17	0.028 (0.03, 0.92)
Hypotension n (%)	3 (5)	2 (10)	0.63	>0.999 (0.09, 4.24)
Bradycardia n (%)	1 (5)	3 (15)	3.35	0.605 (0.32, 35.36)
Hypoxia n (%)	2 (10)	1 (5)	0.47	>0.999 (0.04, 5.69)

Data are presented as mean ± SD or number(%); OR Odds ratio, CI Confidence interval; P < 0.05 denotes statistical significance